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at www.jvascsurg.org.DISCUSSIONDr John Ricotta (Washington, D.C.). You showed a remark-
able ability to discriminate between deciles of stenosis using ultra-
sound. It’s sometimes difﬁcult to do that using angiography. I
wonder how conﬁdent you are that you can discriminate between
a 70% to 80% stenosis and an 80% to 90% stenosis or a 60% to 70%
and a 70% to 80%. This would be a very unusual observation. I
realize you’re quite adept at this, but it’s certainly not something
we would expect in most labs.
Dr Stavros K. Kakkos.Well, this wasn’t the aim of the present
study, but it has been shown in the late ’90s, when these criteria
were published, that there was good correlation with angiography.
Dr Ricotta. But in this study did you correlate your ultra-
sound measurements with angiographic measurements? There
are also a whole series of studies using repeatability and variability
of angiographic measurements that suggests that there is about an
8% to 10% variation from one reader to another, and even inter-
reader variability is at the 10% range.
Dr Kakkos. I agree. However, all ultrasound scans were re-
ported centrally. The exam was reviewed carefully by experienced
readers and we used, as I said, combinations of velocities and
velocity ratios.
Dr Richard Cambria (Boston, Mass). Dr Kakkos, congratula-
tions on another ACSRS report. I followed this study in publica-
tions very carefully and used some of the material in an address
at this Society last year.
But I wonder a little bit about your conclusion. You showed at
the beginning, in your background slide, some of the prior data
that indicates that plaque progression is a risk factor, so I wonder
why your conclusion that says regression, which was a rare event in
your study, might be used to monitor or guide therapy. Shouldn’t
the conclusion be that the observation of progression should be an
important factor in clinical decision-making?
Our group has studied this issue of the control of carotid pla-
que, or lack thereof, with modern medical therapy. And as you
showed, a relatively small percentage of your patients were on
optimal medical therapy. In a paper to be published next month
in the Journal of Vascular Surgery, our data, even in patients
with what all would consider to be optimal medical therapy,
suggests that this medical therapy fails in a high percentage of
patients. So I wouldn’t want you to leave the audience with the
impression that modern medical therapy is going to be effective
in plaque regression.
Dr Kakkos. Unfortunately, progression was relatively rare.
And we know from previous studies that its positive predictive
value in predicting of future stroke is around 20%.
Additionally, progression wasn’t signiﬁcant in multivariate
analysis. So we have to be honest and objective when interpreting
our results. The only actual positive ﬁnding of our study was
regression, so this is why I report it that way.
Dr Ricotta. I don’t see anybody else up, so I guess I’m going
to get to ask one more question. You only saw regression in your
most severe stenosis; is that correct?Dr Kakkos. This is correct, yes.
Dr Ricotta. So would your recommendation for somebody
with a severe stenosis be to monitor them in the hopes that they
show regression, or would it be to operate on them because they
have the other characteristics that your study has shown are asso-
ciated with an increased stroke rate?
Dr Kakkos. Regression occurred more often in plaques that
were over 80% ECST, which is 60% NASCET, so it was moderate
to severe stenosis.
Dr Ricotta. But you didn’t get any regression in those
patients; you only got regression in the 80% and 90% group.
Dr Kakkos. No, that’s where regression was more frequent,
in patients with severe stenosis. Now, regarding the reason that
happened, to have at the same time occlusion and regression
both being more frequent, this might indicate the presence of an
unstable plaque that has not only the ability to progress to occlu-
sion but also to regress. That’s my interpretation of the ﬁndings.
Dr Pierre Karam (Montreal, Quebec, Canada). We would
like to leave with an idea about the degree of stenosis. You classi-
ﬁed stenosis very preciselye50, 60, 70, 80, 90. What are the
numbers that worry you? At what time do you worry that this
lesion is really severe and you should do something?
Dr Kakkos. We used peak systolic velocity and also peak
systolic intrastenotic velocity over the peak systolic velocity of
the common carotid; both are well-known criteria. Additionally,
we used the peak systolic velocity intrastenotic velocity over the
end-diastolic velocity of the common carotid artery. These are all
well-known criteria, and as I said, we used the combination for
criteria.
DrWilhelm Sandmann (Duisburg, Germany). Just a practical
remark. Several, several years ago when Dr Bonnet from London,
Ontario, tried to criticize the surgery on asymptomatic carotid
artery stenosis, a lot of studies were set up. And we had also one
in Dusseldorf under the leadership of Michael Henrich, who was
a very critical neurologist. And at that time, the caseload of carotid
endarterectomy was reduced by about 50% per year. But after the
study was over, the caseload was more than tripled. And the infor-
mation from the neurologists around Henrich was that all of them
were very glad that the trial was over because they were convinced
that the tight stenosis has to be taken away.
So I would take up the comment of Dr Ricotta and ask you,
do you think really that in a patient with a signiﬁcant or, as we
better say, critical carotid artery stenosis, the time has come to
propose medical treatment, or shouldn’t we do medical treatment
probably in the beginning with the plaque and when the patient is
at risk?
Dr Kakkos. As we have published twice, the main endpoint,
the purpose of the ACSRS, was to identify high-risk groups. And if
the risk is extremely high, the aim is to operate on. If you’re going
to replace surgery with best medical therapy, then we need
a randomized study. And CREST II, for sure, will try to answer
this question.
